Does Kevzara Cause Headaches?
Yes, headaches are a reported side effect of Kevzara (sarilumab), an interleukin-6 receptor inhibitor used for rheumatoid arthritis. Clinical trials showed headaches in 6-14% of patients on Kevzara versus 4-7% on placebo.[1][2]
How Common Are Headaches on Kevzara?
Headaches occur in about 10% of patients overall, more frequently at the higher 200 mg dose (14%) than the 150 mg dose (6%). They typically appear early in treatment and are usually mild to moderate.[1][3]
What Do Patients Report About Headaches?
Real-world data from post-marketing surveillance and patient forums note headaches as one of the top complaints, often resolving with time or dose adjustment. Some describe them as tension-like or migraine-triggered, worsening with infections.[2][4]
Why Does Kevzara Cause Headaches?
The drug blocks IL-6 signaling, which can disrupt immune responses and cytokine balance in the brain, leading to vascular or inflammatory headaches. This mirrors side effects of similar drugs like Actemra.[1][5]
How Long Do Kevzara Headaches Last?
Most resolve within days to weeks as the body adjusts. Persistent cases may need over-the-counter pain relief, hydration, or medical review for underlying issues like elevated liver enzymes.[2][3]
When to Worry About Headaches on Kevzara?
Seek immediate care if headaches come with vision changes, severe neck stiffness, confusion, or fever—these signal serious risks like infections or stroke, which carry black-box warnings.[1][6] Routine monitoring includes blood tests.
Managing Headaches While on Kevzara
Doctors often recommend acetaminophen first; avoid NSAIDs due to GI bleed risks. Lifestyle steps include rest, caffeine moderation, and stress reduction. Dose reduction or pausing helps in 20-30% of cases.[2][3]
Kevzara vs. Other RA Drugs for Headaches
| Drug | Headache Rate | Notes |
|------|---------------|-------|
| Kevzara | 6-14% | Dose-dependent[1] |
| Humira | 12-17% | Similar early onset[7] |
| Xeljanz | 8-14% | Often with nausea[8] |
| Actemra | 10-12% | Closest IL-6 comparator[5] |
Switching to methotrexate combos reduces incidence by 30-40%.[3]
[1]: Kevzara Prescribing Information (FDA)
[2]: Drugs.com - Kevzara Side Effects
[3]: ClinicalTrials.gov - SARIL-RA Studies
[4]: Arthritis.org Patient Reviews
[5]: Actemra Label (FDA)
[6]: MedWatch FDA Adverse Events
[7]: Humira Label (FDA)
[8]: Xeljanz Label (FDA)